BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $439,000 | -51.8% | 3,700 | -43.9% | 0.00% | -33.3% |
| Q4 2021 | $910,000 | +39.4% | 6,600 | +40.4% | 0.01% | -14.3% |
| Q3 2021 | $653,000 | +68.3% | 4,700 | +17.5% | 0.01% | +75.0% |
| Q2 2021 | $388,000 | +67.2% | 4,000 | +17.6% | 0.00% | +100.0% |
| Q1 2021 | $232,000 | -37.1% | 3,400 | -20.9% | 0.00% | -50.0% |
| Q4 2020 | $369,000 | +57.7% | 4,300 | +19.4% | 0.00% | +33.3% |
| Q3 2020 | $234,000 | -25.5% | 3,600 | -16.3% | 0.00% | -25.0% |
| Q2 2020 | $314,000 | -59.8% | 4,300 | -71.7% | 0.00% | -55.6% |
| Q1 2019 | $782,000 | – | 15,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |